Market Overview
The major factors for the growth of the optogenetics market include
the potential diagnostic tool in the field of neurosciences, rapid
growth of advanced technology, and increasing use of multimodal
imaging.
Download the full report:
https://www.reportbuyer.com/product/5826181/?utm_source=PRN
NEW YORK, Nov. 12, 2019 /PRNewswire/ -- Optogenetics is a
new research method that has revolutionized neuroscience over the
last years and opened up completely new possibilities to develop a
deeper understanding of the function of the human brain. This
technique allows researchers to study the neurological activity
patterns within specific brain cells and gives rise to thoughts,
behaviors, and memories at an unprecedented precision level. In
this way, it helps to find cures and treatments for neurological
and psychiatric disorders, such as depression, addiction,
schizophrenia, and Parkinson's disease. Researchers are now moving
forward with concrete plans to treat neurological diseases by
developing collaborations with pharmaceutical companies to help
them use optogenetics in animal research, to develop novel drug
targets for human diseases. Improvement and technological
advancements in toolsets, such as neural connectivity, cell
phenotyping tools, neural recording and imaging tools, have further
enhanced and helped the growth of the optogenetics market in
neuroscience. The advantage of optogenetics over other
neuromodulation techniques is its high-temporal specificity
combined with cellular precision. Thus, the increasing research in
neuroscience and brain studies has further helped in fueling the
growth of the optogenetics market.
Scope of the Report
As per the scope of this report, optogenetics refers to a range of
optical techniques to elicit a physiological response in targeted
biological systems, in the absence of pharmacology and electric
stimulation. Optogenetics controls the neural activity by combining
the genetic engineering and optical tools and is widely used in
neuroscience for modulation of neural circuits with a high degree
of precision and specificity.
Key Market Trends
Light Emitting Diode (LED) is the Segment by Light Equipment is
Expected to Observe Fast Growth
LEDs are found to surpass the lasers in every aspect. The LEDs are
found to be cheaper, smaller, more reliable, and easier to control.
They are being incorporated into implants, allowing the untethered
light delivery. The major drawback, and the reason they have not
been as widely adopted by the optogenetics community is their
difficulty toward coupling the light into a fiber optic cable with
high efficiency. Although individual LEDs can emit as much as five
watts of light, the light is emitted in all directions, rather than
in a coherent beam. These are one of the major factors that are
restricting growth. However, a recent class of fiber-coupled LEDs
offers much higher intensities of fiber-coupled light. Hence, there
are many advances in both LED technologies and their applications.
Effective LED therapies are used in treating cutaneous and
neurological diseases. The researchers in LEDs, imaging, light
therapy, and optogenetics have understood the basic principles, and
hence, they are stimulating the application of LEDs in health
care.
North America is Expected to
Dominate the Market
North America is expected to be
the leading market for the use of the optogenetic device, primarily
in academic and research labs. There is an increase in the number
of neuronal diseases, such as epilepsy in the United States with at least 2.9 million
adults and children being affected and also a steady increase in
the number of neuropsychiatric disorders, which is expected to
drive the growth of the optogenetic market. The most common
optogenetics application today is with live animals and is rapidly
being used in various academic and research labs across the
country, which helps in driving the market globally. There are many
advancements in neuroscience that are made possible by the BRAIN
initiative (Brain Research through Advancing Innovative
Neurotechnologies), a massive, collaborative, private-public funded
project aimed at better understanding the human brain. The
USD 100 million was committed to the
federal 2014 budget to the BRAIN initiative and has increased
funding by USD 100 million each year
since 2014. These technologies may open new doors that may boost
the optogenetics market in the United
States. The RetroSense therapeutics in 2016, has also
completed the low dose cohort in the clinical trial of novel gene
therapy application of optogenetics. Hence, all these factors have
helped in the growth of the market.
Competitive Landscape
The market studied is a moderately consolidated market owing to the
various small and large market players. Some of the market players
are Addgene, Cobalt Inc., Coherent Inc., Gensight Biologics,
Laserglow Technologies, Noldus Information Technology, Scientifica,
Shanghai Laser & Optics Century Co. Ltd, and Thorlabs Inc.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client's requirements
- 3 months of analyst support
Download the full report:
https://www.reportbuyer.com/product/5826181/?utm_source=PRN
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that
provides all market research reports from top publishers
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com
View original
content:http://www.prnewswire.com/news-releases/optogenetics-market---growth-trends-and-forecast-2019---2024-300956576.html
SOURCE ReportBuyer